Impact of anaemia on clinical outcome in patients with atrial fibrillation undergoing percutaneous coronary intervention: Insights from the AFCAS registry

BMJ Open

Volumn 4, Issue 5, 2014, Pages

  Puurunen, Marja ^a   Kiviniemi, Tuomas ^b   Nammas, Wail ^b   Schlitt, Axel ^c   Rubboli, Andrea ^d   Nyman, Kai ^e   Karjalainen, Pasi ^f   Kirchhof, Paulus ^g,h   Lip, Gregory Y H ^g   Airaksinen, Juhani K E ^b  

^a FINNISH RED CROSS BLOOD SERVICE   (Finland)

^b TURKU UNIVERSITY HOSPITAL   (Finland)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

^d MAGGIORE HOSPITAL   (Italy)

^e Central Finland Central Hospital   (Finland)

^f SATAKUNTA CENTRAL HOSPITAL   (Finland)

^g UNIVERSITY HOSPITAL MÜNSTER   (Germany)

^h UNIVERSITY OF BIRMINGHAM   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTIVITAMIN K; CLOPIDOGREL; DALTEPARIN; ENOXAPARIN; FIBRINOGEN RECEPTOR ANTAGONIST; HEMOGLOBIN; HEPARIN; HIRULOG; PROTON PUMP INHIBITOR;

ACUTE CORONARY SYNDROME; AGED; ANEMIA; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CEREBROVASCULAR DISEASE; CHADS2 SCORE; CHRONIC KIDNEY DISEASE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY STENT; DEVICE THERAPY; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG ELUTING STENT; EUROPE; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INTERMITTENT PNEUMATIC COMPRESSION DEVICE; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OBSERVATIONAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; PROSPECTIVE STUDY; REGISTER; SECONDARY CARE CENTER; STENT THROMBOSIS; TREATMENT OUTCOME; VASCULAR CLOSURE DEVICE; ATRIAL FIBRILLATION; COMPLICATION; POSTOPERATIVE COMPLICATIONS;

AGED; ANEMIA; ATRIAL FIBRILLATION; FEMALE; HUMANS; MALE; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES; REGISTRIES; TREATMENT OUTCOME;

EID: 84901049425     PISSN: None     EISSN: 20446055     Source Type: Journal    
DOI: 10.1136/bmjopen-2013-004700     Document Type: Article

References (22)

1. Rubboli A, Halperin JL, Airaksinen KE, et al. Antithrombotic therapy in patients treated with oral anticoagulation undergoing coronary artery stenting. An expert consensus document with focus on atrial fibrillation. Ann Med 2008;40:428-36.
2. Rubboli A, Colletta M, Valencia J, et al. for the WARfarin, Coronary STENTing (WAR-STENT) Study Group. Periprocedural management and in-hospital outcome of patients with indication for oral anticoagulation undergoing coronary artery stenting. J Interv Cardiol 2009;22:390-7.
3. Lip GYH, Huber K, Andreotti F, et al. Antithrombotic management of atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing coronary stenting: executive summary - a Consensus Document of the European Society of Cardiology Working Group on Thrombosis, endorsed by the European Heart Rhythm Association (EHRA) and the European Association of Percutaneous Cardiovascular Interventions (EAPCI). Eur Heart J 2010;31:1311-18.
4. Faxon DP, Eikelboom JW, Berger PB, et al. Consensus document: antithrombotic therapy in patients with atrial fibrillation undergoing coronary stenting. A North-American perspective. Thromb Haemost 2011;106:522-84.
5. Rubboli A, Dewilde W, Huber K, et al. The management of patients on oral anticoagulation undergoing coronary stent implantation: a survey among interventional cardiologists from eight European countries. J Interv Cardiol 2012;25:163-9.
6. McKechnie RS, Smith D, Montoye C, et al. Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2). Prognostic implication of anemia on in-hospital outcomes after percutaneous coronary intervention. Circulation 2004;110:271-7. (Pubitemid 38955496)
7. Nikolsky E, Mehran R, Aymong ED, et al. Impact of anemia on outcomes of patients undergoing percutaneous coronary interventions. Am J Cardiol 2004;94:1023-7. (Pubitemid 39336435)
8. Dündar C, Oduncu V, Erkol A, et al. In-hospital prognostic value of hemoglobin levels on admission in patients with acute ST segment elevation myocardial infarction undergoing primary angioplasty. Clin Res Cardiol 2012;101:37-44.
9. Ayhan E, Aycicek F, Uyarel H, et al. Patients with anemia on admission who have undergone primary angioplasty for ST elevation myocardial infarction: in-hospital and long-term clinical outcomes. Coron Artery Dis 2011;22:375-9.
10. Kiviniemi T, Karjalainen P, Rubboli A, et al. Thrombocytopenia in patients with atrial fibrillation on oral anticoagulation undergoing percutaneous coronary intervention. Am J Cardiol 2013;112:493-8.
11. Schlitt A, Rubboli A, Lip GY, et al. for the AFCAS (Management of patients with Atrial Fibrillation undergoing Coronary Artery Stenting Study Group). The management of patients with atrial fibrillation undergoing percutaneous coronary intervention with stent implantation: in-hospital-data from the atrial fibrillation undergoing coronary artery stenting study. Catheter Cardiovasc Interv 2013;82:E864-70.
12. Mehran R, Rao SV, Bhatt DL, et al. Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the bleeding academic research consortium. Circulation 2011;123:2736-47.
13. [No authors listed] Nutritional anaemias. Report of a WHO scientific group. World Health Organ Tech Rep Ser 1968;405:5-32.
14. Pilgrim T, Vetterli F, Kalesan B, et al. The impact of anemia on long-term clinical outcome in patients undergoing revascularization with the unrestricted use of drug-eluting stents. Circ Cardiovasc Interv 2012;5:202-10.
15. Lee PC, Kini AS, Ahsan C, et al. Anemia is an independent predictor of mortality after percutaneous coronary intervention. J Am Coll Cardiol 2004;44:541-6. (Pubitemid 39078176)
16. Kim TH, Koh YS, Chang K, et al. CathOlic university of Korea - percutAneous Coronary inTervention registry investigators. Improved anemia is associated with favorable long-term clinical outcomes in patients undergoing PCI. Coron Artery Dis 2012;23:391-9.
17. Kitai Y, Ozasa N, Morimoto T, et al. on behalf of the CREDO-Kyoto registry investigators. Prognostic implications of anemia with or without chronic kidney disease in patients undergoing elective percutaneous coronary intervention. Int J Cardiol 2013;168:5221-8.
18. Hosseini SK, Ansari MJ, Lotfi Tokaldany M, et al. Association between preprocedural hemoglobin level and 1-year outcome of elective percutaneous coronary intervention. J Cardiovasc Med 2014;15:331-5.
19. Manzano-Fernández S, Pastor FJ, Marín F, et al. Increased major bleeding complications related to triple antithrombotic therapy usage in patients with atrial fibrillation undergoing percutaneous coronary artery stenting. Chest 2008;134:559-67.
20. Toma C, Zahr F, Moguilanski D, et al. Impact of anemia on platelet response to clopidogrel in patients undergoing percutaneous coronary stenting. Am J Cardiol 2012;109:1148-53.
21. Foley RN, Parfrey PS, Hamett JD, et al. The impact of anemia on cardiomyopathy, morbidity, and mortality in end-stage renal disease. Am J Kidney Dis 1996;28:53-61. (Pubitemid 26231466)
22. Maluenda G, Lemesle G, Ben-Dor I, et al. Value of blood transfusion in patients with a blood hematocrit of 24% to 30% after percutaneous coronary intervention. Am J Cardiol 2009;104:1069-73.